Professional Documents
Culture Documents
net/publication/233419325
CITATIONS READS
53 8,544
1 author:
Ingolf Cascorbi
Christian-Albrechts-Universität zu Kiel
410 PUBLICATIONS 14,382 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Ingolf Cascorbi on 16 May 2014.
546 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56
MEDICINE
Learning goals
This CME article gives examples of interactions at the
pharmacodynamic level, mainly using the example of
nonsteroidal anti-inflammatory drugs (NSAIDs). The the use of anti-infectives or in pain therapy. When the
focus is on demonstrating the systematics of pharma- effect of one drug is impeded by another, the effects of
cokinetic interactions. The learning goals follow from these drugs are antagonistic.
this: knowledge of important and frequent Even barely observable undesired effects can po-
● pharmacodynamic interactions tentiate each other in a dangerous manner. For example,
● pharmacokinetic interactions at the absorption if fluoroquinolones are combined with macrolides such
and excretion levels, and as erythromycin, this can result in QT prolongation.
● pharmacokinetic interactions at the drug metab- The combination of ACE inhibitors with potassium-
olism level, chiefly of cytochrome P450 enzymes sparing diuretics such as amiloride can increase potass-
The review article is based on a selective literature ium retention so strongly that life-threatening
search in PubMed and publicly accessible databases hyperkalemia ensues. Interactions of nonsteroidal anti-
such as http://medicine.iupui.edu/clinpharm/ddis/. The inflammatory drugs (NSAIDs) are demonstrated below
clinical manifestation of interactions can vary greatly. as an example of pharmacodynamic interactions.
Inadequate lowering of blood pressure and a blood
pressure drop that may be so extreme as to cause hypo- Pharmacodynamic interactions of NSAIDs
volemic shock can both result from pharmacodynamic Platelet-related interactions—It is generally known
and/or pharmacokinetic interactions. To avoid serious that simultaneous administration of NSAIDs increases
consequences so far as possible from the outset, there- the COX-1-mediated inhibition of thromboxane syn-
fore, requires the ability to make better predictions thesis and hence the risk of gastrointestinal bleeding in
about drug interactions. In some cases, however, de- a synergistic manner. A particular property of the acidic
sired interactions can improve the therapeutic effect, anti-inflammatory ibuprofen is its specific, reversible
e.g., if local bioavailability is increased by inhibition of binding to COX-1, which prevents acetylsalicylic acid
the metabolic pathways. (ASA) from acetylating the serine residue at position
529 of the COX-1 protein. Irreversible and hence long-
Pharmacodynamic interactions lasting inhibition of COX-1-mediated thromboxane A2
The term “pharmacodynamic interactions” refers to in- synthesis by ASA can thus be prevented and the cardiac
teractions in which drugs influence each other’s effects risk of patients with coronary heart disease can increase
directly. As a rule, for example, sedatives can potentiate (8).
each other. The same is true of alcohol, which can Long-term clinical observations confirm these ex
potentiate the sedative effects of many drugs. vivo observations (e5), which appear also to hold for
Often, however, a pharmacodynamic interaction is naproxen (e6). Accordingly, patients with coronary
actually desired, if mutually potentiating effects in the heart disease on ASA prophylaxis should not take
same direction (synergistic effects) are aimed at, e.g., in ibuprofen or naproxen on a regular basis.
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56 547
MEDICINE
548 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56
MEDICINE
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56 549
MEDICINE
550 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56
MEDICINE
Leber_Fotolia abhijith3747
turn increasing the
return to normal until 3 days after the subjects drank
risk of bleeding
one glass of grapefruit juice (e17). The clinical rel-
evance of phenprocoumon is debated, but, at the least, Inactive metabolites
excessive amounts of citrus fruits should be avoided in
patients receiving anticoagulation treatment with
vitamin K antagonists.
Antidepressants—Selective serotonin reuptake in-
hibitors (SSRIs) are potent inhibitors of CYP2D6 Interaction must be expected for several days after
(fluoxetine, paroxetine) (e18) and CYP1A2 (fluvoxa- the last administration of SSRIs, because of their long
mine). This has consequences for the coadministration half-life (Box 3).
of other drugs. In everyday practice, however, one must Quinolones—Quinolones such as ofloxacin and ci-
also watch out for interactions between antidepressants profloxacin are primarily inhibitors of CYP1A2, which
and common medical drugs such as certain beta- is also involved in metabolism of theophylline or cloza-
blockers. Fluoxetine and paroxetine also inhibit the me- pine. Simultaneous administration of, for example,
tabolism of the beta-blocker metoprolol and can thus ciprofloxacin and theophylline can lead to a rise in the
cause lowering of blood pressure, bradycardia, and plasma concentration of theophylline, with correspond-
other undesired effects. ing clinical symptoms of cardiac and gastrointestinal
Fluvoxamine, on the other hand, inhibits CYP1A2 unwanted effects (19). The bioavailability of quino-
and can thus increase the toxicity of theophylline or lones themselves can be markedly restricted if they are
clozapine. A fatal interaction between fluoxetine and given at the same time as bivalent or trivalent cations,
clozapine has also been reported (e19). such as are contained in antacids or zinc or iron formu-
The inhibition of CYP2D6 can also reduce the lations (Box 4).
formation of active metabolites of codeine into mor- Proton pump inhibitors (PPIs)—Proton pump in-
phine or tramadol into O-desmethyltramadol. It has hibitors such as omeprazole, lansoprazole, pantopra-
been shown in large studies that the inhibition of zole, or rabeprazole inhibit cytochrome P450 2C19
CYP2D6-mediated activation of the anti-estrogen tam- (CYP2C19) to varying degrees. Omeprazole in particu-
oxifen to endoxifen through SSRIs is associated with lar (esomeprazole less so) is a substrate and inhibitor of
increased breast cancer mortality (18). CYP2C19. Recently, a discussion has arisen about the
Apart from the pharmacokinetic interactions, an- consequences of its interaction with the platelet aggre-
other aspect to consider with SSRIs is potentiation of gation inhibitor clopidogrel. Clopidogrel is a prodrug
the serotonergic effects. It is known that simultaneous that is metabolized to its active metabolites in two
administration of moclobemide can trigger serotonin steps, and CYP2C19 plays an essential part in this. Ho
syndrome and is contraindicated for that reason. et al. showed a rise from 20.8% to 29.8% in the rate of
However, other drugs with serotonergic effects such deaths or rehospitalization of patients being treated
as tramadol or triptans can increase the risk of with clopidogrel for acute coronary syndrome and si-
serotonin syndrome. When triptans such as sumatriptan multaneously with PPIs (adjusted odds ratio 1.25 [95%
are used at the same time, there is an additional risk CI, 1.11 to 1.41]) (20). A similar association was found
of coronary artery constriction and hypertension. in carriers of the nonactive genetic variants of
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56 551
MEDICINE
TABLE 3
Interactions at the cytochrome P450 enzyme level: selection of relevant substrates for which, when used in combination with inhibitors or indu-
cers of the same enzyme, either increased effects and increased occurrence of unwanted effects, or reduced effects or loss of effect must be
anticipated (modified from [24])
* Prodrug
CYP2C19 (21, e20). Both the CYP2C19*2-splice-site information, without mentioning any drugs by name,
variant and the *3 missense variant lead to a complete advises against the simultaneous use of strong
loss of effect of the protein. Among white people, 3% CYP2C19 inhibitors.
are homozygote CYP2C19*2 carriers, while *3 carriers Conversely, omeprazole can inhibit the break-
contribute to the “poor metabolizer” status of people of down of other drugs. An example is citalopram, the
Asian origin. A systematic meta-analysis of follow-up metabolization of which is slowed down by omeprazole
studies confirmed the association between CYP2C19 (e21), and the risk of unwanted effects such as
polymorphisms and platelet inhibition by clopidogrel, QT prolongation rises. Omeprazole also inhibits
but clinically no significant effect on the risk of car- demethylation of the benzodiazepine diazepam. At a
diovascular events was shown (22). The US Food and dose of 20 mg, omeprazole results in a 36% increase in
Drug Administration (FDA) points out in the safety in- the half-life of diazepam and a 27% reduction in its
formation on clopidogrel that the drug will have re- clearance; giving 40 mg omeprazole increases the
duced effectiveness in CYP2C19 nonmetabolizers. half-life by 130% and clearance by 54%. Lansoprazole
With regard to interactions, the FDA recommends also inhibits the metabolization of diazepam, although
choosing the proton pump inhibitor pantoprazole rather more weakly; this evidence did not appear for
than omeprazole, if possible. The German drug pantoprazole (e22).
552 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56
MEDICINE
TABLE 4
Interactions with the most important cytochrome P450 enzymes: inhibitors and inducers (modified from [25])
Miscellaneous
Aprepitant +, Amiodarone
Cimetidine +
Diltiazem
Naringin + (in citrus fruits)
Verapamil +
Inducers
Tobacco smoke Rifampicin Carbamazepine
Omeprazole (oxcarbazepine less so)
Efavirenz
Hyperforin (in St. John’s wort)
Phenobarbital
Phenytoin
Rifampicin
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56 553
MEDICINE
BOX 3
● Inhibition of cytochrome P450 1A2 by quinolones (prin- 5. Holt S, Schmiedl S, Thurmann PA: Potentially inappropriate medications
in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107(31–32):
cipally pefloxacin and ciprofloxacin, less by ofloxacin, 543–51.
levofloxacin, or moxifloxacin)
6. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmo-
● Combination with NSAIDs (except for aspirin) increases hamed M: Adverse drug reactions in hospital in-patients: a prospective
analysis of 3695 patient-episodes. PLoS One 2009; 4: e4439.
tendency to seizures
7. Hartmann B, Czock D, Keller F: Drug therapy in patients with chronic
● Combination with macrolides (prolongation of QT inter- renal failure. Dtsch Arztebl Int 2010; 107(37): 647–56.
val with risk of malignant cardiac arrhythmias such as 8. Catella-Lawson F, Reilly MP, Kapoor SC, et al.: Cyclooxygenase
torsade de pointes) inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;
345: 1809–17.
554 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56
MEDICINE
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2012; 109(33–34): 546–56 555
MEDICINE
Please answer the following questions to participate in our certified Continuing Medical Education pro-
gram. Only one answer is possible per question. Please select the answer that is most appropriate.
Question 1 Question 6
Which drug can increase the platelet inhibiting effect of A patient who has received a renal transplant is on ciclosporin therapy.
NSAIDs? He says he has been feeling down recently and is therefore taking St.
a) Erythromycin John’s wort. What could be one effect of the comedication?
b) Mirtazapine a) Increased coagulation time
c) Citalopram b) Increased ciclosporin toxicity
d) Rifampicin c) Hypertrichosis
e) Fluconazole d) Increased thrombosis risk
e) Transplant rejection
Question 2
The antihypertensive effect of ACE inhibitors can be Question 7
specifically reduced by inhibition of renal prostaglandin A patient who has been taken off the beta-blocker metoprolol is treated
synthesis. Which of the following drugs interacts in this with fluoxetine for depression. What unwanted effect should be ex-
process? pected?
a) Low-dose ASA a) Bradycardia
b) Hydrochlorothiazide b) Skin bleedings
c) Verapamil c) Increase in blood pressure
d) Diclofenac d) Anemia
e) Morphine e) Hyperglycemia
Question 3 Question 8
ASA inhibits platelet aggregation. Which analgesic can What is the name of the flavonoid contained in citrus fruits that is an
reduce this effect if given at the same time? inhibitor of CYP3A4?
a) Ibuprofen a) Apigenin
b) Diclofenac b) Naringin
c) Meloxicam c) Chrysin
d) Paracetamol d) Luteolin
e) Etoricoxib e) Hesperetin
Question 4 Question 9
Which drug increases the bioavailability of digoxin by What effect should be expected in a patient taking clopidogrel and
inhibiting the P-glycoprotein efflux transporter? omeprazole simultaneously?
a) Dabigatran a) Omeprazole increases the side effects of clopidogrel
b) Hypericin b) Increased risk of thrombotic-thrombocytopenic purpura
c) Rifampicin c) Omeprazole raises the plasma concentration of the active clopidogrel
d) Clarithromycin metabolite
e) Morphine d) Reduction of the clopidogrel-mediated inhibition of platelet aggregation
e) Clopidogrel inhibits the breakdown of omeprazole
Question 5
Which drugs, if taken at the same time, increase the risk Question 10
of gastrointestinal bleeding due to an additive interac- The term “synergy” is used in pharmacodynamics to describe mutual
tion? influencing of the effects of two drugs. What does synergy mean?
a) Paracetamol + triptan a) Mutual strengthening of effect
b) Phenprocoumon + NSAID b) The effect can only be achieved by giving the drugs at the same time
c) SSRI + paracetamol c) An effect that is at least more than the additive effect of both drugs
d) Quinolone + warfarin d) Reduction of the side effects
e) Macrolide + NSAID e) Mutual canceling out (neutralization) of effects